Bioniche Limited supports access to selected oral liquid formulations for paediatric patients and patients with dysphagia, including patients who have difficulty swallowing tablets or capsules. These formulations may support treatment adherence where a liquid preparation is clinically appropriate and prescribed by a healthcare professional. Products may be sourced through valid prescriptions, PPB permit processes or UHPT access pathways where applicable. Availability is subject to product sourcing, documentation review, regulatory requirements and final confirmation.

Some patients and hospitals require medicines that are unavailable, out of stock, rarely imported, discontinued locally, supplied through limited channels, or required in a specific brand, strength or formulation. Bioniche Limited supports hard-to-find medicine requests by checking availability through appropriate sourcing channels and advising on the next practical access route. For non-stock or import-only items, timelines depend on manufacturer availability, documentation, regulatory requirements, payment confirmation, PPB permit processing and logistics.

Some health products may not be registered, routinely stocked or commercially available in Kenya but may still be required for a specific patient, hospital or clinical need. Bioniche Limited supports special import and UHPT access requests through a documentation-led process aligned with applicable Pharmacy and Poisons Board requirements. This service may apply to unregistered medicines, orphan drugs, oncology therapies, rare disease products, medical devices, transplant medicines, immunotherapies and other specialty health technologies.